| Country | Best estimate 2012 n (95% CI) | Cases detected and reported | Cases commencing treatment | ||||||
| 2009 | 2010 | 2011 | 2012 n (% of estimated) | 2009 | 2010 | 2011 | 2012 | ||
| Afghanistan | 1100 (0–2900)# | 0 | 19 | 19 | 31 (3) | 0 | 0 | 21 | 38 |
| Angola | 1700 (780–2500)# | 0 | 3 | 40 | 45 (3) | 0 | 3 | 5 | 45 |
| Azerbaijan | 2800 (2600–3000) | 0 | 552 | 811 | 596 (21) | 0 | 286 | 592 | 406 |
| Bangladesh | 4200 (3100–5200) | 0 | 339 | 509 | 513 (12) | 352 | 339 | 390 | 513 |
| Belarus | 2200 (2100–2200) | 1342 | 1576 | 1594 | 1604 (73) | 0 | 200 | 1446 | 2478 |
| Brazil | 1700 (1400–2000) | 449 | 573 | 566 | 684 (40) | 398 | 573 | 630 | 713 |
| China | 59 000 (52 000–66 000) | 474 | 2792 | 1601 | 3007 (5) | 458 | 1222 | 1155 | 1906 |
| DPR Korea | 3800 (3000–4600)# | 0 | 0 | 37 | 25 (1) | 0 | 0 | 25 | 50 |
| DR Congo | 2900 (670–5100)# | 91 | 87 | 121 | 81 (3) | 176 | 191 | 128 | 262 |
| Ethiopia | 2000 (1200–2900) | 233 | 140 | 212 | 284 (14) | 88 | 120 | 199 | 289 |
| India | 64 000 (49 000–79 000) | 1660 | 2967 | 4237 | 16 588 (26) | 1136 | 2967 | 3384 | 14 143 |
| Indonesia | 6900 (5200–8500) | 0 | 182 | 383 | 428 (6) | 20 | 142 | 260 | 426 |
| Kazakhstan | 7000 (6900–7200) | 3644 | 7387 | 7408 | 7608 (>100) | 3209 | 5705 | 5261 | 7213 |
| Kenya | 2800 (840–4800)# | 150 | 112 | 166 | 225 (8) | 140 | 118 | 156 | 202 |
| Kyrgyzstan | 1800 (1600–2000) | 785 | 566 | 806 | 958 (53) | 545 | 566 | 492 | 775 |
| Rep. Moldova | 1700 (1600–1800) | 1069 | 1082 | 1001 | 894 (53) | 334 | 791 | 765 | 853 |
| Mozambique | 2000 (1300–2700) | 140 | 165 | 283 | 266 (13) | 103 | 87 | 146 | 213 |
| Myanmar | 6000 (4600–7500) | 815 | 192 | 690 | 778 (13) | 64 | 192 | 163 | 442 |
| Nigeria | 3600 (2700–4500) | 28 | 21 | 95 | 107 (3) | 0 | 23 | 38 | 125 |
| Pakistan | 11 000 (0–29 000)# | 49 | 444 | 344 | 1602 (15) | 368 | 424 | 344 | 1045 |
| Peru | 2200 (2100–2300) | 1578 | 1048 | 1663 | 1225 (56) | 1856 | 1702 | 1374 | 1510 |
| Philippines | 12 000 (9300–15 000) | 1073 | 522 | 1148 | 679 (6) | 501 | 548 | 2397 | 1918 |
| Papua New Guinea | 1100 (930–1300)# | 0 | 0 | 15 | 58 (5) | 0 | 0 | 60 | 82 |
| Republic of Korea | 2200 (1800–2700) | 0 | 450 | 516 | 1212 (55) | 0 | 0 | 307 | 1212 |
| Russian Federation | 46 000 (43 000–49 000) | 14 686 | 13 692 | 13 785 | 13 612 (30) | 8143 | 13 692 | 18 902 | 18 452 |
| South Africa | 8100 (6900–9400) | 9070 | 7386 | 10 085 | 15 419 (>100) | 4143 | 5402 | 5643 | 6494 |
| Thailand | 1800 (1400–2200) | 0 | 0 | 510 | 492 (27) | 296 | 9 | 123 | 0 |
| Ukraine | 6800 (6500–7000) | 3482 | 5336 | 4305 | 6934 (>100) | 3186 | 3870 | 4957 | 7672 |
| Uzbekistan | 4000 (3700–4300) | 654 | 1023 | 1385 | 1728 (43) | 464 | 628 | 855 | 1491 |
| Viet Nam | 3800 (3000–4600) | 217 | 101 | 601 | 273 (7) | 307 | 101 | 578 | 713 |
| Total | 280 000 (190 000–330 000) | 41 689 | 48 757 | 54 936 | 77 956 (28) | 26 287 | 39 901 | 50 796 | 71 681 |
Data are presented as n, unless otherwise stated. The % detected may exceed 100% if estimates were too conservative, and if linkage between clinical and laboratory registers was inadequate. Further information can be found in the Materials and methods section. #: based on modelled values from countries in the same region.